Lacrimal gland ductal carcinomas: Clinical, Morphological and Genetic characterization and implications for targeted treatment

Keyphrases

• Clinical Characterization 100%
• Genetic Characterization 100%
• Lacrimal Gland 100%
• Targeted Treatment 100%
• Ductal Carcinoma in Situ 100%
• Morphological Characterization 100%
• Older Men 60%
• Breast Carcinoma 40%
• Chemosis 40%
• Immunohistochemistry 20%
• Therapeutic Potential 20%
• Headache 20%
• Tumor 20%
• Malignancy 20%
• Protein Expression 20%
• High-level Expression 20%
• Signaling Pathway 20%
• Diplopia 20%
• Salivary Gland 20%
• Estrogen Receptor 20%
• Fluorescence in Situ Hybridization 20%
• Human Epidermal Growth Factor Receptor 2 (HER2) 20%
• Point mutation 20%
• Aberrations 20%
• Proptosis 20%
• Androgen Receptor 20%
• Homozygous Deletion 20%
• New Therapeutics 20%
• Carcinoma Cells 20%
• Progesterone Receptor 20%
• Relevant Genes 20%
• HER2 Testing 20%
• Next-generation Sequencing 20%
• HER2 Amplification 20%
• HER2-targeted Therapy 20%
• Genetic Events 20%
• Cytokeratin 19 (CK19) 20%
• Therapeutic Goals 20%
• Genetic Patterns 20%
• Comedonecrosis 20%
• Actionable Target 20%
• Corneal Abscess 20%
• Scirrhous 20%
• Xerophtalmia 20%
• Cystic Nodule 20%
• HER2 Signaling 20%

Medicine and Dentistry

• Morphology 100%
• Targeted Therapy 100%
• Lacrimal Gland 100%
• Ductal Carcinoma 100%
• Chemosis 40%
• Malignant Neoplasm 20%
• Neoplasm 20%
• Cancer 20%
• Headache 20%
• Carcinoma 20%
• Signal Transduction 20%
• Protein Expression 20%
• Immunohistochemistry 20%
• Salivary Gland 20%
• Abscess 20%
• Fluorescence in Situ Hybridization 20%
• Protein P53 20%
• Breast Carcinoma 20%
• Estrogen Receptor 20%
• Exophthalmos 20%
• Androgen Receptor 20%
• Point Mutation 20%
• Carcinoma Cell 20%
• Progesterone Receptor 20%
• Next Generation Sequencing 20%
• Diplopia 20%